AMPD3 anticorps (FITC)

N° du produit ABIN1403186

L’anticorps Lapin Polyclonal anti-AMPD3 a été validé pour WB et IF (p). Il convient pour détecter AMPD3 dans des échantillons de Humain, Souris et Rat.

Aperçu rapide pour AMPD3 anticorps (FITC) (ABIN1403186)

Antigène: AMPD3 (Adenosine Monophosphate Deaminase 3 (AMPD3))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AMPD3 est conjugé à/à la FITC

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-AMPD3 anticorps (FITC)

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human AMPD3

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur AMPD3

Antigène: AMPD3 (Adenosine Monophosphate Deaminase 3 (AMPD3))

Autre désignation: AMPD3

Sujet:

Synonyms: Adenosine monophosphate deaminase isoform E, Adenosine monophosphate deaminase 3, AMP aminohydrolase, AMP deaminase 3, AMP deaminase isoform E, Ampd3, AMPD3_HUMAN, Erythrocyte AMP deaminase, Erythrocyte specic AMP deaminase, Erythrocyte type AMP deaminase, Myoadenylate deaminase.

Background: AMP deaminase plays a critical role in energy metabolism.Involvement in diseaseDefects in AMPD3 are the cause of adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE), also known as erythrocyte AMP deaminase deficiency. AMPDDE is a metabolic disorder due to lack of activity of the erythrocyte isoform of AMP deaminase. It is a clinically asymptomatic condition characterized by a 50 % increase in steady-state levels of ATP in affected cells. Individuals with complete deficiency of erythrocyte AMP deaminase are healthy and have no hematologic disorders.

ID gène: 272